| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jean-Charles Piette | Q73305204 |
| Ronald A. Asherson | Q73406057 | ||
| Munther A. Khamashta | Q73418907 | ||
| Yehuda Shoenfeld | Q1515807 | ||
| Ricard Cervera i Segura | Q53547424 | ||
| P2093 | author name string | D Erkan | |
| M-C Boffa | |||
| PG de | |||
| P2860 | cites work | Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases | Q33339201 |
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients | Q33502956 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients | Q34435380 | ||
| Thrombotic storm: when thrombosis begets thrombosis | Q34467096 | ||
| P433 | issue | 7 | |
| P921 | main subject | catastrophic antiphospholipid syndrome | Q5051580 |
| P304 | page(s) | 530-534 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | |
| P478 | volume | 12 |
| Q95359130 | Q95359130 |
| Q53245134 | A 26-year-old white man with a systemic lupus erythematosus flare and acute multiorgan ischemia: Vasculitis or thrombosis? |
| Q33437339 | A 3-year follow-up of a patient with acute renal failure caused by thrombotic microangiopathy related to antiphospholipid syndrome: case report |
| Q90529323 | A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans |
| Q46529932 | A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection |
| Q55279180 | A importância de reconhecer a síndrome antifosfolípide na medicina vascular. |
| Q83450164 | A spontaneous intercostal artery hemorrhage in systemic lupus erythematosus |
| Q51030619 | A therapeutic challenge: catastrophic anti-phospholipid syndrome with diffuse alveolar haemorrhage. |
| Q51144375 | Abdominal pain, flank pain, blurry vision, and lower extremity weakness in a 16-year-old female. |
| Q37196191 | Acute central retinal artery occlusion associated with livedoid vasculopathy: a variant of Sneddon's syndrome. |
| Q41824978 | All that seems sepsis is not sepsis |
| Q38422451 | All that seems sepsis is not sepsis: However, is this case report really a case of catastrophic antiphospholipid syndrome? |
| Q91792514 | Alveolar Hemorrhage, a Rare and Life-Threatening Complication of Catastrophic Antiphospholipid Syndrome |
| Q42956219 | Alveolar and serum antiphospholipid antibodies in acute respiratory distress syndrome associated with catastrophic antiphospholipid syndrome |
| Q37853593 | An approach to the patient with retiform purpura |
| Q88984101 | An extraordinary case of recurrent stroke, disseminated thrombosis and endocarditis |
| Q92639094 | Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery |
| Q37628253 | Anesthetic management of antiphospholipid syndrome patients who underwent cardiac surgery: three cases report |
| Q55128267 | Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases. |
| Q94940476 | Antiphospholipid Syndrome |
| Q33921875 | Antiphospholipid antibodies in critically ill patients |
| Q36915667 | Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome |
| Q30235423 | Antiphospholipid syndrome |
| Q55891386 | Antiphospholipid syndrome |
| Q64046338 | Antiphospholipid syndrome |
| Q91390119 | Antiphospholipid syndrome - an update |
| Q35553410 | Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients |
| Q35680777 | Antiphospholipid syndrome infectious origin |
| Q38596401 | Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review |
| Q38410376 | Antiphospholipid syndrome: an update |
| Q37729831 | Antiphospholipid syndrome: frequency, main causes and risk factors of mortality |
| Q37842673 | Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. |
| Q58602902 | Antiphospholipid syndrome: state of the art on clinical practice guidelines |
| Q36566894 | Antiphospholipids Syndrome Complicated by a Systemic Capillary Leak-Like Syndrome Treated With Steroids and Intravenous Immunoglobulins: A Case Report |
| Q35905997 | Autonomic dysfunction and primary antiphospholipid syndrome: a frequent and frightening correlation? |
| Q35751482 | Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome |
| Q37210831 | Bentall Surgery in a Patient with Cold Agglutinin and Antiphospholipid Antibody: Double Trouble |
| Q45230040 | CAPS Registry |
| Q37076964 | CAPS: a rare acute abdomen. |
| Q33419886 | Catastrophic APS in the context of other thrombotic microangiopathies |
| Q92758910 | Catastrophic Antiphospholid Syndrome - An Unusual Case Report |
| Q53758664 | Catastrophic Antiphospholipid Syndrome. |
| Q92986354 | Catastrophic antiphospholipid antibody syndrome as a first manifestation of primary antiphospholipid antibody syndrome in a middle-aged man |
| Q80167214 | Catastrophic antiphospholipid syndrome |
| Q37223858 | Catastrophic antiphospholipid syndrome (CAPS) induced by influenza A virus subtype H1N1. |
| Q35603756 | Catastrophic antiphospholipid syndrome (CAPS): A rare and fatal encounter |
| Q45912780 | Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'. |
| Q40488176 | Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: the first case reported |
| Q36729464 | Catastrophic antiphospholipid syndrome associated with malignancies (case report and review of the literature). |
| Q35953379 | Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases |
| Q43275141 | Catastrophic antiphospholipid syndrome in a patient with Down syndrome |
| Q37077038 | Catastrophic antiphospholipid syndrome in childhood: presentation with an inferior caval vein mass |
| Q51699221 | Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour--a case report. |
| Q88012285 | Catastrophic antiphospholipid syndrome presenting with pulmonary hemorrhage: case report |
| Q41870499 | Catastrophic antiphospholipid syndrome presenting with sudden renal failure: The lesson lies in vascular lesions |
| Q42247683 | Catastrophic antiphospholipid syndrome triggered by sepsis |
| Q50949676 | Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. |
| Q33412407 | Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications |
| Q27009935 | Catastrophic antiphospholipid syndrome: a clinical review |
| Q45294664 | Catastrophic antiphospholipid syndrome: a rare cause of disseminated microvascular thrombotic injury - a case report with pathological and molecular correlative studies |
| Q84774055 | Catastrophic antiphospholipid syndrome: first signs in the neonatal period |
| Q26825077 | Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease |
| Q36951067 | Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font |
| Q37339827 | Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse |
| Q34526465 | Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome |
| Q48657018 | Chronic catastrophic-like antiphospholipid syndrome: a “smoldering” variant? |
| Q54951796 | Clinical Report of Probable Catastrophic Antiphospholipid Syndrome in Pregnancy. |
| Q38657043 | Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers |
| Q37340369 | Clinical and laboratory features of the catastrophic antiphospholipid syndrome |
| Q37562787 | Clinical and laboratory manifestations of yemeni patients with systemic lupus erythematosus. |
| Q38994352 | Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort |
| Q33384874 | Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort |
| Q90468632 | Co-existing Bilateral Pulmonary Embolism and Intra-cardiac Mass: A Case of Catastrophic Antiphospholipid Syndrome-like Disease |
| Q64092966 | Complement in the Pathophysiology of the Antiphospholipid Syndrome |
| Q40780447 | Crohn's Disease Causes a Catastrophe |
| Q37642830 | Current management of antiphospholipid syndrome-related thrombosis |
| Q30235356 | Diagnosis and management of catastrophic antiphospholipid syndrome |
| Q47982275 | Diagnosis and management of the antiphospholipid syndrome |
| Q37970586 | Duration of anticoagulation after cerebral venous sinus thrombosis |
| Q58048140 | Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation |
| Q98177119 | Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications |
| Q89588653 | Epidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based Study |
| Q35382247 | Extensive vascular occlusions as initial presentations of systemic lupus erythematosis. A case report and review of literature |
| Q40013107 | Familial antiphospholipid syndrome presenting as bivessel arterial occlusion in a 17-year-old girl |
| Q33438290 | Fatal antiphospholipid syndrome following endoscopic transnasal-transsphenoidal surgery for a pituitary tumor: A case report |
| Q34122035 | Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis |
| Q37311073 | Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases |
| Q37266831 | Hepatic infarction in a pregnant woman with antiphospholipid syndrome and triple antibody positivity: A case report focusing on catastrophic antiphospholipid syndrome |
| Q33374874 | Hughes Syndrome: the antiphospholipid syndrome--a clinical overview |
| Q37101366 | Hughes syndrome (the antiphospholipid syndrome): 25 years old. |
| Q92966518 | IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases |
| Q64955185 | Immunologic findings precede rapid lupus flare after transient steroid therapy. |
| Q35625927 | Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay |
| Q36334472 | Indications for plasma exchange in systemic lupus erythematosus in 2005. |
| Q36339540 | Infectious origin of the antiphospholipid syndrome |
| Q94562624 | Intensive Care Society State of the Art 2018 Abstracts |
| Q28292418 | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) |
| Q36458164 | Laboratory diagnosis and management challenges in the antiphospholipid syndrome |
| Q33376910 | Livedo reticularis as a criterion for antiphospholipid syndrome |
| Q37339051 | Malignancies and catastrophic anti-phospholipid syndrome |
| Q33423034 | Management of the antiphospholipid syndrome |
| Q28196178 | Management of the antiphospholipid syndrome |
| Q33385438 | Massive cerebrovascular infarct due to the catastrophic antiphospholipid syndrome in a patient with idiopathic thrombocytopenic purpura |
| Q60938900 | Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations |
| Q48502389 | Moving towards a molecular taxonomy of autoimmune rheumatic diseases |
| Q37404485 | New approaches for managing antiphospholipid syndrome |
| Q37168035 | New developments in lupus-associated antiphospholipid syndrome |
| Q34140319 | New therapeutic targets for the antiphospholipid syndrome |
| Q37269605 | Occult pulmonary mucosa-associated lymphoid tissue lymphoma presenting as catastrophic antiphospholipid antibody syndrome. |
| Q38697342 | Organ Damage and Quality of Life in Antiphospholipid Syndrome. |
| Q33412248 | Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy |
| Q89986376 | Pediatric APS: State of the Art |
| Q41100232 | Pediatric antiphospholipid syndrome |
| Q52349399 | Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview. |
| Q38211785 | Perioperative management of antiphospholipid antibody-positive patients |
| Q41643629 | Plasma Exchange in the Management of Catastrophic Antiphospholipid Syndrome |
| Q33374604 | Plasma exchange for systemic lupus erythematosus |
| Q34436283 | Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report |
| Q40059466 | Polyspecificity of Anti-lipid A Antibodies and Its Relevance to the Development of Autoimmunity |
| Q90261755 | Post-partum catastrophic antiphospholipid syndrome presenting with shock and digital ischaemia - A diagnostic and management challenge |
| Q60954866 | Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria |
| Q33378048 | Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients |
| Q38132095 | Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage |
| Q53134970 | Probable catastrophic antiphospholipid syndrome complicated with primary sclerosing cholangitis. |
| Q33401365 | Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy |
| Q38443308 | Recurrent episodes of hemorrhagic alveolitis in relapsing catastrophic antiphospholipid syndrome: the same side of the dark moon |
| Q33361019 | Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation |
| Q41922298 | Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss |
| Q43196044 | Recurrent thrombotic events after catastrophic antiphopholipid syndrome |
| Q38838855 | Renal involvement in primary antiphospholipid syndrome |
| Q37802034 | Respiratory involvement in systemic lupus erythematosus |
| Q36319341 | Review: intravenous immunoglobulin therapy and thromboembolic complications |
| Q27021256 | Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome |
| Q33906941 | SEQUENTIAL CENTRAL RETINAL VEIN AND OPHTHALMIC ARTERY OCCLUSIONS IN A PEDIATRIC CASE OF PRIMARY ANTIPHOSPHOLIPID SYNDROME |
| Q39237507 | Segmental small bowel necrosis associated with antiphospholipid syndrome: a case report |
| Q33595036 | Simultaneous Occurrence of Deep Vein Thrombosis and Carotid Artery Thrombosis in Antiphospholipid Antibody Syndrome |
| Q35617645 | Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay |
| Q32182200 | Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation |
| Q90181658 | Successful treatment of catastrophic antiphospholipid syndrome with therapeutic plasma exchange: a case report |
| Q33380344 | Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up |
| Q45088823 | Susac's syndrome or catastrophic antiphospholipid syndrome? |
| Q30243901 | Systematic review of case reports of antiphospholipid syndrome following infection. |
| Q24543555 | Systemic lupus erythematosus |
| Q55933861 | Systemic lupus erythematosus |
| Q53159273 | Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. |
| Q53189388 | The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. |
| Q88399624 | The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository |
| Q35636571 | The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients |
| Q79870443 | The antiphospholipid syndrome |
| Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
| Q36928593 | The antiphospholipid syndrome: still an enigma |
| Q33382243 | The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems |
| Q28072610 | The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus |
| Q55340119 | The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement. |
| Q90029250 | The rheumatology/hematology interface: CAPS and MAS diagnosis and management |
| Q38158240 | The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity |
| Q64326912 | The role of hydroxychloroquine in catastrophic antiphospholipid syndrome case: Series of two case reports and review of literature |
| Q80377257 | The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome |
| Q36053839 | The role of plasmapheresis in critical illness |
| Q33216930 | The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome |
| Q33365607 | The systemic nature of the antiphospholipid syndrome |
| Q33366832 | Therapeutic apheresis in the Philippines |
| Q87873270 | Therapeutic apheresis in the treatment of catastrophic antiphospholipid syndrome |
| Q53695276 | Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes. |
| Q64248267 | Thrombocytopenia in the intensive care unit |
| Q28211887 | Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties |
| Q33368977 | Thrombotic microangiopathy in adult Still's disease |
| Q38135335 | Top 10 clinical research developments in antiphospholipid syndrome |
| Q38755260 | Treatment of catastrophic antiphospholipid syndrome |
| Q35940099 | Treatment of the antiphospholipid antibody syndrome |
| Q35308972 | Treatment of the antiphospholipid syndrome |
| Q33394237 | Trend of indications for therapeutic plasma exchange at an Iranian university hospital |
| Q61805318 | Tumid lupus erythematosus-like pseudovasculitic lesions in catastrophic antiphospholipid syndrome |
| Q43923996 | Two cases of catastrophic antiphospholipid syndrome |
| Q37738701 | Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome |
| Q36108261 | Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications |
| Q35555909 | Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome |
| Q33408341 | Vascular endothelial cell function in catastrophic antiphospholipid syndrome: a case report and review of the literature |
| Q35940089 | What is antiphospholipid syndrome? |
| Q34340560 | When You are About to Diagnose Chronic Hemolytic Uremic Syndrome, Please Think More Deep |
| Q84600606 | [Gangrene as an initial manifestation of a catastrophic antiphospholipid syndrome] |
| Q83079608 | [Respiratory involvement in systemic lupus erythematosus] |
| Q86630002 | [The catastrophic antiphospholipid antibody syndrome: case report and review of the literature] |
| Q93111593 | [What are the indications for rescue procedures? : Systemic rheumatic diseases in the intensive care unit] |
Search more.